Nikkiso DBB-06 Hemodialysis System

Register to receive a free US Dialysis Devices & Concentrates Market report synopsis and brochure

The Medical Division of Nikkiso America, Inc., announced the U.S. launch of the DBB-06 Hemodialysis System equipped with Dialysis Dose Monitor (DDM), after receiving 510(k) clearance from the U.S. Food and Drug Administration (FDA) in March. The DBB-06 System with DDM was tailored to address U.S. dialysis clinic needs and it offers exceptional efficacy, efficiency and reliability at an affordable life cycle cost. This launch marks the entrance into the U.S. renal market for Nikkiso Medical.

Nikkiso Medical is one of the world’s leading manufacturers of dialysis machines and a market leader in Europe and Asia. The company is the second largest producer of hemodialysis equipment globally with over 100,000 hemodialysis machines in clinical use.

“After achieving a strong position in the global markets due to our outstanding product reliability, we are now providing a new option in hemodialysis equipment for U.S. clinics,” said Thomas Kelly, president of Nikkiso America’s Medical Division. “Nikkiso America is committed to continuing our company’s legacy of innovation to improve hemodialysis treatment outcomes while also addressing the needs of the care team.”

A unique feature integrated into the DBB-06 System is the Blood Volume Monitor, designed to help the clinician evaluate and react to the patient’s hydration status by continuously monitoring relative blood volume during treatment. The Blood Volume Monitor does not require additional disposables or cost per treatment. The DBB-06 System with DDM also includes:

  • A full range of features, such as ultrafiltration profiling, ultrapure dialysate, patient blood pressure monitoring
  • A self-prompting, intuitive touchscreen user interface and the storage and recall of up to 16 patient prescriptions
  • Enhanced automation, with programmed self-test/extracorporeal circuit priming and automatic disinfection and decalcification, saving time
  • Data connection to the electronic medical record (EMR)
  • Exceptional quality and reliability
  • The Dialysis Dose Monitor to assist the care provider in real-time to ensure an adequate treatment for the patient
  • Safety features, including a battery backup system in the case of power failure and continuous monitoring of the fluid removal system
  • Extremely quiet operation

The DBB-06 Hemodialysis System with DDM is now available across the country. To learn more about the DBB-06 Hemodialysis System equipped with Dialysis Dose Monitor, visit:

About Nikkiso America
Nikkiso America, Inc. is headquartered in San Diego, Calif., and has offices and divisions based around the U.S., operating Nikkiso Co., Ltd.’s U.S.-based Medical, Aerospace and Industrial Divisions. The businesses include acute blood purification products, chronic dialysis systems, carbon fiber products for aerospace applications, pump products and fluid technologies, water conditioning systems for thermal and nuclear power plants, and particle size characterization. To learn more, visit

For Further Information
More on the dialysis equipment and concentrate market in the U.S. can be found in the report published by iData entitled U.S. Market for Dialysis Equipment and Concentrates, which covers the U.S. market as a whole, as well as market sub-segments for hemodialysis machines, dialysis catheters, dialysis concentrate, dialyzers, dialyzer reprocessing machines, hemodialysis bloodlines and tubing sets, AV fistula needles, AV access grafts, declotting devices, introducer sheaths and guidewires, and water treatment systems

The global series on the market for dialysis equipment and concentrates covers the U.S. and Canada. Full reports provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. Register online or email us at [email protected] for a U.S. Market for Dialysis Equipment and Concentrates report brochure and synopsis.

About Procedure Tracker
Procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by state, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.

About Reimbursement Tracker
iData Research’s Reimbursement Policy Tracker enables medical device, dental, pharmaceutical and healthcare professionals to receive real-time policy updates from hundreds of insurance companies and 60,000+ policies across all therapeutic areas in the United States.

Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.

Like us on Facebook:
Follow us on LinkedIn:
Follow us on Twitter: